Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) had Return on Tangible Equity of -31.09% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.02M |
|
$-17.20M |
|
-- |
|
$0.02M |
|
$17.69M |
|
$-17.68M |
|
$0.54M |
|
$-17.14M |
|
$-17.14M |
|
$-17.20M |
|
$-17.20M |
|
$-17.20M |
|
$-17.20M |
|
$-17.68M |
|
$-17.50M |
|
55.72M |
|
55.72M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$62.60M |
|
$3.94M |
|
$4.76M |
|
$67.36M |
|
$11.43M |
|
$0.45M |
|
$0.56M |
|
$11.99M |
|
$55.37M |
|
$55.32M |
|
$55.37M |
|
55.79M |
|
| Cash Flow Statement Financials | |
$-39.96M |
|
$-1.17M |
|
$0.38M |
|
$78.23M |
|
$37.84M |
|
$-40.39M |
|
$2.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.48 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-110481.30% |
|
-110481.30% |
|
-- |
|
-107118.80% |
|
-107500.00% |
|
$-40.37M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
0.04M |
|
-31.06% |
|
|
Return on Tangible Equity |
-31.09% |
-25.53% |
|
-30.82% |
|
$0.99 |
|
$-0.72 |
|
$-0.72 |
|